$Centessa Pharmaceuticals (CNTA.US)$ and $Schrodinger (SDGR....

The agreement will give Centessa subsidiary Orexia Therapeutics access to Schrodinger's computing platform. The platform allows for high performance computing in order to accurately predict the effectiveness of the target of interest.

The terms require Orexia to handle preclinical research activities, clinical development, and commercialization of potential candidates.